Sinbaglustat,441061-33-2

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Sinbaglustat

CAS No. : 441061-33-2

MCE 国际站：Sinbaglustat

产品活性：Sinbaglustat (OGT2378) 是葡萄糖神经酰胺合成酶 (GCS) 和非溶酶体葡萄糖神经酰胺酶 (GBA2) 的双重抑制剂。Sinbaglustat 是一种可透过血脑屏障的的口服N-烷基亚氨基糖。Sinbaglustat 可用于与溶酶体功能障碍相关的中枢神经退行性疾病的研究。

研究领域：Neuronal Signaling

作用靶点：Glucosylceramide Synthase (GCS)

In Vitro: Sinbaglustat (OGT2378; 20 μM) reduces the synthesis of glucosylceramide and ganglioside by 93% and >95% in MEB4 melanoma cells compared with untreated MEB4 cells, respectively, without either cytotoxic or antiproliferative effects.
GBA2 is an enzyme involved in the catabolism of glycosphingolipids (GSLs). Sinbaglustat is 50-fold more potent in inhibiting GBA2 than GCS.

In Vivo: Sinbaglustat (OGT2378; administered p.o., in the powdered chow, at a dose of 2500 mg/kg/day, corresponding to 35-40 mg of Sinbaglustat per mouse per day) is highly effective in impeding melanoma tumor growth in vivo. The effectiveness of p.o. Sinbaglustat in this murine model suggests that inhibition of glycosphingolipid synthesis is a promising approach to inhibit tumor progression.

相关产品：Bioactive Compound Library Plus  |  Neuronal Signaling Compound Library  |  CNS-Penetrant Compound Library  |  Neurodegenerative Disease-related Compound Library  |  Lipid Metabolism Compound Library   |  Anti-Pulmonary Fibrosis Compound Library  |  Ibiglustat  |  Miglustat hydrochloride  |  Lucerastat  |  Glucosylceramide synthase-IN-2  |  D-threo-PPMP hydrochloride  |  Glucosylceramide synthase-IN-1  |  AMP-Deoxynojirimycin  |  D-threo-PDMP  |  Fucosyltransferase 8  |  G43  |  G43-C3-TEG  |  Genz-123346  |  Glucosylceramide synthase-IN-3  |  Nizubaglustat  |  PDMP hydrochloride  |  UDP-GalNAc:β-1,3-N-acetylgalactosaminyltransferase 2  |  α-N-Acetylglucosaminidase

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds